11:30 am–12:30 pm Friday, September 6

Foundations of Pediatric Neuro-Oncology (214)

Pediatric central nervous system (CNS) tumors are a diverse group of tumors that together represent the most common solid tumor in children, with approximately 4,300 new cases diagnosed in the US each year. Management of children with CNS tumors requires knowledge of the unique aspects of care associated with this particular patient population beyond general oncology care.

Read more...
Speaker:
Cheryl Fischer, MSN RN CPNP
CNE Hours
1
11:30 am–12:30 pm Friday, September 6

The Forgotten Organ- Nephrotoxicity and other Kidney Disorders in Childhood Cancer (213)

Development of kidney disease is a significant occurrence among children and adolescent patients treated for cancer and require prompt attention, intervention, and follow-up. Renal disease in the pediatric cancer setting is often an underdiagnosed condition, partly due to the emphasis and priority of achieving a cure. Renal disease in the young patient with cancer may result from the malignant process itself or from adverse effects from treatment, including chemotherapy, radiation therapy, surgery, or supportive therapy.

Read more...
11:30 am–12:30 pm Friday, September 6

Moving Qualitative Evidence to Nursing Practice – The Case for Qualitative Metasynthesis (212)

Pediatric hematology/oncology nurses need to develop and apply research translation skills so that they can promote evidence-based nursing care practices that lead to desired quality care outcomes for their patients and families. Quantitative research is essential to know the optimal antiemetic regimen to prevent chemotherapy-induced nausea and vomiting. However, this form of evidence will not inform nurses about the child’s experience of nausea or how to advise parents to help their children cope with this symptom at home beyond giving medicines.

Read more...
10–11:15 am Friday, September 6

Strengthening the Local Chapters of APHON through Shared Experiences (LCM)

The Local Chapter Committee Liaisons and Chapter Leaders will convene to discuss topics such as fundraising, community service, education, and recruitment and retention that affect the functioning of local chapters. These will be discussed in a round table manner and then presented to the whole group. Attendees will be able to take this knowledge back to their local chapters and continue forward thinking momentum, recruitment of new members, retention of seasoned members, and implementation of a variety of fundraising and community projects for pediatric hematology and oncology families.

Read more...
5:00–6:00 pm Thursday, September 5

Global Health in Pediatric Oncology: A Practical Guide for Nurses (209)

In high-income countries (HIC), the survival of childhood cancer has reached over 80% in recent years. However, in low- and middle-income countries (LMIC), where the majority of the world’s children with cancer live, survival remains around 20%. Many hospitals and organizations in HICs have partnered with those in LMICs to help bridge this survival gap. Frequently, nurses from HICs who participate in these efforts have limited experience working in limited-resource settings.

Read more...
5:00–6:00 pm Thursday, September 5

Decoding the Mystery of Gene Therapy – An Overview for Nursing (208)

The decoding of the human genome has provided scientists and researchers a new pathway to developing potential curative therapies for life-threatening or otherwise fatal illnesses. The development of these gene therapies is moving at lightning speed, translating this novel therapy from the bench to the bedside at a record pace. What was once thought of as a highly experimental approach, these therapies are quickly becoming standard of care, as demonstrated by the recent Food and Drug Administration (FDA) approval of several gene therapies, specifically Chimeric Antigen Receptor (CAR) T cell for B cell acute lymphoblastic leukemia and diffuse large B cell lymphoma. These therapies are complex both in their scientific development and, more importantly, in their clinical delivery.

Read more...
Speaker:
Colleen Dansereau, MSN RN CPN
CNE Hours
1
5:00–6:00 pm Thursday, September 5

Non-Pharmacologic Treatment of Pain in Sickle Cell Disease (207)

Sickle cell disease (SCD) is characterized by episodes of severe and unpredictable pain that requires adaptation to remain healthy and functional. A more holistic view of pain assessment and treatment is necessary to address the bio-psychosocial needs of the individual in or at risk for pain. The treatment of SCD should include all available modalities to enhance the disease process, pain management, and psychosocial functioning.

Read more...
Speaker:
Megan Coco, MSN RN CPNP-PC
CNE Hours
1
5:00–6:00 pm Thursday, September 5

Symptom Assessment and Associated Biomarkers (206)

Altered sleep and increased fatigue are reported as two of the most distressing symptoms during treatment and into survivorship. Prevalence of disrupted sleep and fatigue have been reported to be higher among patients treated for CNS tumors, those treated with radiation therapy, solid tumors, and Hodgkin Lymphoma; however, changes in sleep and fatigue have been reported across all cancer diagnoses. To elucidate the biological mechanism underlying these symptoms, symptom science has evolved from descriptive studies of symptom occurrence to the measurement of biological processes.

Read more...
3:45–4:45 pm Thursday, September 5

Implementing the USP 800 Guidelines: What does it mean for pediatric nurses? (203)

The United States Pharmacopeia (USP) has put forth new guidelines for the handling of medications that have been deemed hazardous by The National Institute for Occupational Safety and Health (NIOSH), known as USP 800. All healthcare and manufacturing institutions are mandated to implement the guidelines by December 2019.

Read more...
3:45–4:45 pm Thursday, September 5

Back to Basics: The ABCs of CBCs (202)

The complete blood count (CBC) is the most common test ordered on our patients. Most hematology/oncology nurses only glance briefly, however, at a patient’s CBC to determine if they meet criteria for chemotherapy administration, blood transfusion, or emergent antibiotics. Have you ever looked beyond the Hgb, PLT, and ANC and wondered what the MCV or IPF may indicate?

Read more...
Speaker:
Karyn Brundige, MSN CPNP
CNE Hours
1
Subscribe to this RSS feed